Table 6 Multivariate analyses for 30-day mortality in the study population.

From: Bacterial distributions and prognosis of bloodstream infections in patients with liver cirrhosis

Factor

Group

N

OR

90% CI

P value

Combined with liver failure

No

664

1.000 (Reference)

Ā 

Yes

188

2.288

1.451

3.609

0.0028

Combined with liver cancer

No

602

1.000 (Reference)

Ā 

Yes

250

2.196

1.366

3.529

0.0064

Complication

No

163

1.000 (Reference)

Ā 

Yes

689

4.663

3.057

7.113

<0.0001

Child-Pugh grade

A

109

1.000 (Reference)

Ā 

B

302

5.483

1.914

15.708

0.0078

C

441

10.499

3.687

29.894

0.0002

Septic shock

No

691

1.000 (Reference)

Ā 

Yes

161

3.959

2.457

6.380

<0.0001

Appropriate antibiotics within 24 h

Yes

612

1.000 (Reference)

Ā 

No

240

8.278

5.460

12.550

<0.0001

ICU

No

697

1.000 (Reference)

Ā 

Yes

155

2.363

1.447

3.861

0.0039

Nosocomial infection

No

329

1.000 (Reference)

Ā 

Yes

523

1.670

1.107

2.520

0.0402

Gram stain

Negative

508

1.000 (Reference)

Ā 

Positive

344

0.465

0.305

0.710

0.0029

  1. Note: Complication: including ascites or hepatorenal syndrome or hepatic encephalopathy or upper gastrointestinal bleeding. Combined with liver failure: cirrhosis with liver failure.